Skip to content

Press Release Archive

Dec 13, 2004

Allergan's BOTOX -- Botulinum Toxin Type A -- Not the Cause of Botulism in Florida Patients  

Dec 3, 2004

Allergan Update Regarding Florida Facility Investigation; Company Urges Physicians to Use Only FDA-Approved and U.S. Licensed Botulinum Toxin Products to Protect Public Health  

Nov 30, 2004

Allergan Update Regarding Florida Facility Reports; No Safety Concerns Found with Any BOTOX -R- Manufacturing Lots  

Nov 29, 2004

Allergan Statement Regarding Florida Facility Reports  

Nov 29, 2004

Allergan Statement Regarding Florida Reports  

Nov 1, 2004

Allergan Reports Third Quarter Operating Results; Pharmaceutical Sales Increased 15 Percent for the Third Quarter; Board of Directors Declares Third Quarter Dividend  

Oct 8, 2004

Jury Rules in Favor of Allergan, Inc.; Judge Dismisses Remaining Claims  

Oct 8, 2004

Allergan Announces Agreement to Discontinue Peplin Collaboration  

Oct 6, 2004

Allergan Announces Quarterly Conference Call  

Sep 27, 2004

Allergan Receives Action Letter for Oral Tazarotene  

Aug 24, 2004

Allergan Files Suit Against Alcon for Patent Infringement  

Aug 2, 2004

Allergan Receives Approvable Letter for LUMIGAN -- bimatoprost-timolol  

Jul 28, 2004

Allergan Announces New Executive Vice President, Research & Development; Scott Whitcup, M.D. to lead Allergan's Worldwide R&D Efforts  

Jul 28, 2004

Allergan Announces New Board Member; Prof. Trevor M. Jones Appointed  

Jul 28, 2004

Allergan Reports Second Quarter Operating Results  

Jul 20, 2004

FDA Approves BOTOX -- Botulinum Toxin Type A -- for Treatment of Severe Underarm Sweating; New Approval Marks Fourth Therapeutic Indication for Allergan's BOTOX Over Last 15 Years  

Jul 9, 2004

Allergan Announces Conference Call to Discuss FDA Advisory Committee Meeting on Oral Tazarotene  

Jul 9, 2004

Allergan Announces Retirement of Board Member Ronald M. Cresswell  

Jul 1, 2004

Allergan Announces Quarterly Conference Call  

Jun 15, 2004

Allergan, Inc. Wins $1.5 Million BOTOX ® Trademark Infringement And Unfair Competition Case Against Mira Life Group, Inc.  

Showing 1-20 of 106
Page: 1 2 3 ... 6
 Next 20